Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CTX”

1,724 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,724 results

Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Large-scale testing (Phase 3)UnknownNCT00002653
What this trial is testing

Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Medical Research Council 1,000
Early research (Phase 1)Active Not RecruitingNCT03655002
What this trial is testing

IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer

Who this might be right for
Recurrent Hepatocellular CarcinomaRefractory Liver CarcinomaStage IV Hepatocellular Carcinoma AJCC v8+2 more
City of Hope Medical Center 8
Not applicableStudy completedNCT00615901
What this trial is testing

Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT02533401
What this trial is testing

Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 34
Not applicableUnknownNCT04937309
What this trial is testing

Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea

Who this might be right for
Breast Cancer
University Hospital, Tours 338
Testing effectiveness (Phase 2)Ended earlyNCT01100944
What this trial is testing

PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies

Who this might be right for
ThymomaThymic Carcinoma
National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)Ended earlyNCT03440411
What this trial is testing

Pom-dex Versus Pom-Cyclo-dex in MM Patients With Biochemical or Clinical Relapse, During Lena Maintenance Treatment

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 9
Testing effectiveness (Phase 2)Study completedNCT01663714
What this trial is testing

Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma.

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 30
Testing effectiveness (Phase 2)WithdrawnNCT03602898
What this trial is testing

Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic Leukemia+10 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT01212887
What this trial is testing

Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+4 more
Cancer Research UK 14
Testing effectiveness (Phase 2)WithdrawnNCT00161564
What this trial is testing

A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT02243371
What this trial is testing

GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab

Who this might be right for
Previously Treated Metastatic Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 93
Testing effectiveness (Phase 2)Study completedNCT01153971
What this trial is testing

Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 47
Testing effectiveness (Phase 2)Ended earlyNCT04243109
What this trial is testing

Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib

Who this might be right for
Multiple Myeloma
Maimónides Biomedical Research Institute of Córdoba 6
Large-scale testing (Phase 3)Looking for participantsNCT04061512
What this trial is testing

Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia

Who this might be right for
Waldenstrom Macroglobulinemia
University College, London 148
Testing effectiveness (Phase 2)UnknownNCT00114309
What this trial is testing

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeGBM+3 more
TransMolecular 66
Testing effectiveness (Phase 2)Study completedNCT00844506
What this trial is testing

P53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer

Who this might be right for
Ovarian Cancer
University Medical Center Groningen 19
Early research (Phase 1)Ended earlyNCT00852709
What this trial is testing

Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaMyeloproliferative Disorders+7 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)Study completedNCT02789332
What this trial is testing

Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency

Who this might be right for
Breast CancerTriple Negative Breast NeoplasmsHRpos Breast Neoplasms+1 more
GBG Forschungs GmbH 107
Load More Results